• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Comparison of outpatient antibiotic prescribing in traditional medical, retail clinic settings

Bioengineer by Bioengineer
July 16, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Bottom Line: Outpatient antibiotic prescribing varied among traditional medical and retail clinic settings and during visits with respiratory diagnoses where antibiotics were inappropriate, patterns that suggest differences in patient mix and antibiotic overuse.

Why The Research Is Interesting: Antibiotic use contributes to antibiotic resistance, and antibiotic overuse is common, especially for viral respiratory infections. This study compared antibiotic prescribing patterns among urgent care centers, retail clinics, emergency departments and medical offices.

Who and When: Outpatient claims data from a 2014 database that captures claims data on people younger than 65 with employer-sponsored insurance

What (Measures and Outcomes): Outpatient claims at urgent care centers, retail clinics, hospital based-emergency departments or medical offices were each assigned a diagnosis (exposure); percentage of visits linked to prescription of antibiotics with a focus on respiratory diagnoses where antibiotics were unnecessary (outcomes)

How (Study Design): This was an observational study. Researchers were not intervening for purposes of the study and cannot control all the natural differences that could explain the study findings.

Authors: Katherine E. Fleming-Dutra, M.D., of the U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, and coauthors

Study Limitations: Researchers could not clinically validate diagnoses in claims data so misclassification was possible, data also are not generalizable to populations not captured in this claims database, and facility codes could not be validated.

Study Conclusions: Antibiotic stewardship, the effort to optimize antibiotic use, across the spectrum of outpatient settings could help to improve antibiotic prescribing and patient care.

Related Material: The patient page, "I Have a Cold – What Do I Need to Know," and the invited commentary, "Overprescription in Urgent Care Clinics – the Fast and the Spurious," by JAMA Internal Medicine Editor Rita F. Redberg, M.D., M.Sc., of the University of California, San Francisco, and coauthors also are available on the For The Media website.

To Learn More: The full study is available on the For The Media website.

(doi:10.1001/jamainternmed.2018.1632)

Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Want to embed a link to this study in your story? Links will be live at the embargo time http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2018.1632

Media Contact

Martha Sharan
[email protected]

@JAMAInternalMed

Share12Tweet7Share2ShareShareShare1

Related Posts

REV-ERBα/BNIP3 Axis Reduces Pulmonary Hypertension via Mitophagy

April 2, 2026

Gomesin Cytotoxicity Driven by Glycosphingolipids, Cholesterol

April 2, 2026

Gut Microbiome’s Role in Gastric Cancer Therapy

April 2, 2026

Spike in Kava-Related Inquiries Reported by Poison Control Centers

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

REV-ERBα/BNIP3 Axis Reduces Pulmonary Hypertension via Mitophagy

Gomesin Cytotoxicity Driven by Glycosphingolipids, Cholesterol

Gut Microbiome’s Role in Gastric Cancer Therapy

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.